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ABSTRACT
The Ensembl Trace Archive (http://trace.ensembl.
org/) and the EMBL Nucleotide Sequence Database
(http://www.ebi.ac.uk/embl/), known together as
the European Nucleotide Archive, continue to see
growth in data volume and diversity. Selected major
developments of 2007 are presented briefly, along
with data submission and retrieval information. In
the face of increasing requirements for nucleotide
trace, sequence and annotation data archiving, data
capture priority decisions have been taken at the
European Nucleotide Archive. Priorities are dis-
cussed in terms of how reliably information can be
captured, the long-term benefits of its capture and
the ease with which it can be captured.
INTRODUCTION
In Europe, the major public repositories for nucleotide
trace, sequence and annotation are the EMBL Nucleotide
Sequence Database (EMBL-Bank) and the Ensembl
Trace Archive (ETA). Together, the two repositories
are known as the European Nucleotide Archive (ENA).
The remit of ENA is the capture and public presentation
of nucleotide sequencing data, including traces, quality
scores, assembly information, biological annotation
and metadata. This data capture is achieved both by
the provision of submission environments tailored to
the needs of data generating communities and by close
collaboration with the other major public repositories
across the world, namely the DNA Databank of Japan (1)
and GenBank (2), each of which are partners in the Inter-
national Nucleotide Sequence Database Collaboration
(INSDC), and the NCBI Trace Archive (3).
During 2007, the ENA has seen continued growth
in both the volume and nature of data represented; at
the time of going to press, the archive comprised over
1.7 billion records covering almost 1.7 trillion (1.710
12)
base pairs of sequence.
As the ENA continues to grow, new challenges are
presented. Novel data types, including those from the
ultra-high-throughput sequencing technologies and meta-
genomics, each demand dedicated data structures and
procedures for their handling. The increased volumes of
data demand rationalization of exactly which pieces of
information are captured, which are validated manually
or automatically and which are stored in the archives.
In this article, we present a summary of the major
milestones and achievements of 2007, provide submission
information and oﬀer a summary of data presentation
across ENA. In the remaining part of the document,
we outline the data capture priorities that we have
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date future growth in data volume and diversity.
MAJOR DEVELOPMENTS IN 2007
Both ETA and EMBL-Bank have continued to grow
exponentially in 2007. At the time of going to press, ETA
holds 1.6 billion traces from almost 1000 organisms,
covering 1.5 trillion base pairs, while EMBL-Bank holds
103 million entries from 300000 organisms, covering
182 billion base pairs. Strong areas of growth include
metagenomic data and genomic data. The genomes
webserver, http://www.ebi.ac.uk/genomes/, which oﬀers
a collection of genomes drawn from EMBL-Bank
sequence entries, cites 4192 completely sequenced organ-
isms, including 52 eukaryotes, 517 bacteria, 47 archaea
and 1814 phage, virus and viroid genomes.
A number of key datasets have been newly presented in
2007 that are of importance to agriculture, medicine,
industry, ancient DNA and ecology. Notable examples
include a working draft WGS dataset from grape
(Vitis vinifera cultivar PN40024, CAAP00000000), WGS
data and ﬁrst assembly of the horse genome (Equus
caballus, CM000377), two further assembled and anno-
tated genomes of the parasite Leishmania [Leishmania
infantum, AM502219-AM502254 and Leishmania brazi-
liensis, AM494938-AM494972; (4)], the industrially
important fungus, Aspergillus niger CBS 513.88
[AM270980–AM270998, AM269948–AM270415; (5)], a
key ancient DNA study, the mammoth fossil metagenome
[CAAM00000000; (6)], the CAMERA global ocean survey
metagenome trace and WGS data [AACY00000000; (7)]
and human whole-genome re-sequencing project data
(ABBA00000000).
Launched late in 2007, the EMBL submission portal
(http://www.ebi.ac.uk/embl/Submission/index.html) pro-
vides a single point of entry for submitters of all ENA
data types. A single user account is used across ENA
submissions; users can register genome and metagenome
projects, initiate submissions to ETA, launch and track
Webin submission sessions for new EMBL-Bank data,
report updates to existing records and launch and track
Webin submission sessions for alignment data.
Finally, search tools and data downloads based around
the ENA Project Database have been made available from
the genomes webserver.
DATA SUBMISSION
All registration, submission and update functionalities
are available from the EMBL submission portal (Figure 1
and Table 2).
Projectregistration
For large-scale genome and metagenome sequencing
projects, projects are registered by submitters as early as
possible. At the time of registration, a unique project
identiﬁer is issued that can be used to refer collectively
to data submitted as part of that project. The project
identiﬁer is of value for users of trace data presented as
part of the ETA and sequence and assembly data
presented as part of EMBL-Bank. At the time of regis-
tration, various project metadata are collected that cover
the taxonomic details of the project, the purpose of the
study and for single organism genome projects, details of
replicons and expected sizes. As time goes on, metadata
can be updated by submitters. When sequence data are
generated, they are associated with the project identiﬁer
through the ‘Universal_project_ID’ ﬁeld in ETA and
in PR lines in EMBL ﬂatﬁle format. Further details are
available at: http://www.ebi.ac.uk/embl/Documentation/
project_guidelines.html.
EMBL-Bank submission
The central submission tool for annotated sequence is
Webin. While Webin has been in service for many years,
it is undergoing redevelopment. Webin currently oﬀers
small-scale submission, ‘bulk’ submission, where the
submitter describes a representative sample entry and
submits variable ﬁeld data subsequently using web forms
or ﬁle upload and submission of novel sequence in
multiple alignment formats. In the coming year, the
underlying technology will be replaced to allow for new
functionalities to be implemented. These new functional-
ities will be rolled out over time in due course, but will
include the option to update existing records, an intuitive
wizard to describe splicing and coding events and the
increased use of standard and personalised templates for
the rapid submission of multiple sequences from large-
scale studies.
Trace submission
Files for trace data submission created by data submitters
can be integrated into ETA. Ahead of submitting data, if
the data are from a new sequencing project, then an ENA
Project should be registered. Submitters should then
e-mail trace-submission@ensembl.org, or follow links
from the EMBL submission portal, to discuss the logistics
of the submission with ETA staﬀ.
Figure 1. EMBL submission portal. The screenshot shows the
submission portal top page, where submission options are presented
to the user.
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Data are presented in a host of ways in order to satisfy as
many diverse user needs as possible. Traces, sequence
entries and project records are available for retrieval
by identiﬁer; sequence similarity search tools are oﬀered
for both ETA and EMBL-Bank data; the term search tool,
SRS, is oﬀered for EMBL-Bank and project records.
For large-scale users, datasets are available for FTP
download or can be sent out in tape format. Where entries
are organized into genomes, genome level services are
presented at the EMBL genomes webserver. URLs to the
appropriate resources are given in Table 2.
DATA CAPTURE PRIORITIES
Data ﬂow into the European repositories through a
variety of pipelines (Figure 2). For ETA, data are sub-
mitted directly by e-mail or FTP and additional data are
captured through regular exchange of new records with
the NCBI Trace Archive. For EMBL-Bank, there
are curated submissions, account submissions, daily
exchange of new data with DDBJ and GenBank, Euro-
pean Patent Oﬃce data input and cross-reference mapping
data captured from external bioinformatics resources.
At the start of data collection in the 1980s, extensive
manual work was required to load data into the database.
It soon became clear that the volume of data expected
would require compromises with respect to the amount of
time spent by staﬀ validating data prior to loading.
Clearly, the exponential growth of the database has
not been reﬂected in a similar expansion of the team
responsible for data loading. When automated sequencing
became available, it was recognized that the newly
established large sequencing centres would be able
to provide ample bioinformatics expertise, given the
scale of their operations and the nature of their funding,
to produce validated database-ready ﬁles for loading
with minimal intervention from database staﬀ. This data
input pipeline gave birth to the system of submission
accounts, of which the database now has 104. Similar
reasoning was applied when ETA was established in 2001
and responsibility for validation of submitted trace data
lies with the submitting group.
While EMBL-Bank submission account holders and
trace submitters have largely been able to satisfy the
requirements of validation prior to database loading,
changes in the nature of the sequencing community have
begun to present new challenges. High-throughput
sequencing became increasingly available to more and
more research groups, through advancing technology
and reduced cost. Currently, the sequencing of prokar-
yotic and simple eukaryotic genomes and the generation
of large amounts of sequence data peripheral to genomes,
such as those from EST and cDNA library sequencing
and mapping projects, are not restricted to the large
sequencing centres. Preferring to provide in-house valida-
tion rather than to rely on the now smaller and more
constrained sequencing teams for these new datasets,
EMBL-Bank chose to route this new breed of large-scale
submissions through its curated submissions pipeline.
Although curated submissions to EMBL-Bank cur-
rently contribute only a limited share of data to ENA, we
feel that the future growth of this pipeline and the impact
it has on other data input pipelines (such as the transfer
of practices and technology to other EMBL-Bank
pipelines and the inﬂuence it has on practices and tech-
nology at collaborators’ sites), warrant its streamlining.
Eﬀorts have therefore been underway for some time in
the development and implementation of validation tech-
nology and future developments in this area have now
been prioritized. In the long term, we expect the curated
submissions pipeline to draw on both robust high-capacity
automation and manual curation in areas where biological
decision-making and communications with submitters
remain essential.
For each data element that might be captured by the
database, three measures have been considered in the
setting of priorities; the long-term value of capturing
the data element, the ease with which it can be captured
and the extent to which it can be validated semantically.
High priority can easily be given to those elements
with high long-term value, simple capture and high
semantic validation potential. For those elements, how-
ever, that show limited long-term value, that are diﬃcult
to capture or have limited semantic validation potential,
the decision to capture or not is less straightforward.
Some of the priority decisions that ENA has made
in this context are described in this section. For the
purposes of this discussion, ‘validation’ refers to the
checking of semantic integrity (both intrinsically and
in relation to broader knowledge) and is mainly con-
cerned with biological concepts, while ‘loading’ refers
to the syntactic checking of content against database
constraints and the subsequent population of database
tables.
Figure 2. Input pipelines into ENA. Data input pipelines into ENA are
shown; the left-hand side of the diagram represents the work of
the data generating group and the right-hand side the work of ENA;
validation refers to the semantic content of data transferred,
particularly the biological content, and loading refers to syntactic
checking of data and upload into the appropriate database.
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ETA records present sequencing traces, quality scores and
base calls (sequence). Next-generation sequencing tech-
nologies promise large volumes of very diﬀerent data and
it is likely that some representation of quality will be
stored along with sequence, although the technology for
dealing with these data types is still under development.
While base quality scores can be stored, sequence alone is
mandatory in EMBL-Bank records. Sequence is largely
stored and presented as submitted to ENA, although for
curated submissions to EMBL-Bank, sporadic vector
contamination and source organism checks are run.
Other than simple syntactic checking, traces, quality
scores and sequence will not be further validated.
Tracedata forexperimental (non-assembly) applications
We expect that the decreasing cost of sequencing will
herald extensive use of sequencing as a general assay for
many types of experiment, whereas ‘traditional’ sequen-
cing has generally been focused on generating assembled
reference genome or mRNA sequence. Such experiments
include sequencing for gene expression, the sequencing of
chromatin immunoprecipitation preparations (so called
‘chIP-seq’) and sequencing of clonally barcoded popula-
tions (such as yeast knockout cell lines) in high-
throughput experiments. Although the cost of sequencing
for each application will be low (hence the feasibility of the
experiment), the overall experiment is likely to remain
comparatively expensive and the sequence will commonly
be of interest to many researchers; this is particularly true
of chIP-seq and gene expression datasets. We expect to
store the trace information in an appropriate short-read
format in ETA, and speciﬁcally not in EMBL-Bank, and
associate the information with metadata relating to the
parent experiment. In the case of gene expression, for
example, metadata will conform to the ‘sample annota-
tion’ components of the MIAMI standard (8). It is likely
that the needs of the experimental community will drive
the development of new standards, in particular through
the interactions between reviewers and journals in pub-
lications covering standard classes of experiment.
We expect from informal publisher contacts that the
journals will have continued demand for the archiving of
these experimental data for future use.
Clerical information
Clerical information includes all information that is added
to archival records for the purposes of tracking, including
submission information, entry and sequence versioning,
EMBL-Bank taxonomic division and dataclass, trace
identiﬁers and accession numbers. It is typically repre-
sented in the trace information section in ETA records and
in the header section in EMBL ﬂatﬁle format. Included in
clerical information are also free text description ﬁelds and
keywords (DE and KW lines in EMBL ﬂatﬁle format),
both of which serve to replicate information already
associated with records, rearranged for the purposes of
search and presentation. Clerical information can be
generated in a highly automated way upon data loading
and is of great user value, so ENA continues to build on
existing automation in this area.
Source metadata
Biological source metadata provide details of the physical
source of nucleic acid molecules represented in the
nucleotide archives and are key to the interpretation of
sequences in the analysis of expression, biodiversity,
evolutionary biology and variation. Included are details
of which molecule has been sequenced, library informa-
tion, where the molecule was obtained, which isolate of
the molecule’s parent organism was used for extraction,
taxonomy of the parent organism, details of the relation-
ship to any host, ecology, community structure and
environmental data and so on (Table 1).
The information has great user value, both for highly
speciﬁc searches and for the large-scale download of
datasets to feed secondary resources. The extent to which
data elements can be validated automatically is limited,
though, and a diversity of validation procedures is req-
uired for breadth of coverage. Given the value, ENA has
prioritized the development of procedures and supporting
technology for the capture and validation of accurate
source metadata, but expects that much of it will continue
to require a degree of manual curation to achieve full
value.
One area of source annotation that has developed
rapidly over the last few years is the description of
environmental sampling associated both with anonymous
sequencing from the environment and with ecological
studies. Such ETA ﬁelds as Latitude and Longitude and
EMBL-Bank qualiﬁers as /environmental_sample,
/lat_lon and /collected_by have been introduced since
2001 to capture sampling information. Based on the
information in these ﬁelds, such services as EMBL World
have been developed (Table 2).
For access to source material for subsequent study,
ENA values the use of those source ﬁelds that refer users
to items in physical collections with long-term commit-
ments to storage. Such centres include herbaria, culture
collections, stock centres and museum collections.
In EMBL-Bank, the qualiﬁer/specimen_voucher has
existed for some time, and in October 2007, a granular
structure has been imposed, allowing users to cite source
institute from a controlled list, collection and accession
number. In December 2007, the new qualiﬁers /culture_
collection and /bio_material will be introduced with
similar structures.
Biological annotation
The understanding of the biological function of compo-
nents of nucleotide sequence is the ultimate intention of
many of the sequencing studies represented in ENA.
Biological feature annotation is the representation of this
understanding against coordinate-deﬁned regions of sub-
mitted sequence. Within ENA, biological annotation is
presented in EMBL-Bank, both in association with
submitted sequence (primary records) and with Third
Party Annotation [TPA, where researchers who have
not generated sequence themselves present alternative
D8 Nucleic Acids Research, 2008, Vol. 36, Database issueannotation of existing sequence, derived from peer
reviewed studies where direct, or inferred, experimental
data are generated; (9)]. The EMBL feature table oﬀers
around 60 feature keys to describe biological features.
Links to a feature deﬁnition browser and the Feature
Table Deﬁnition document are given in Table 2.
The capture of annotation of biological functions is
important, although the extent to which many of the
annotations can be validated computationally is limited.
Transcription, splicing and coding, for example, are well
understood and nature oﬀers ﬁrm rules for such processes
as translation that provide us with powerful validation
tools. Other biological features, such as promoters
and enhancers, on the other hand, oﬀer limited known
options for systematic validation. In general, there are two
principles that can be followed to provide computational
validation of annotation of biological features; ab initio
rules and validation of annotation by inference from
homologous sequences. Ultimately, it is experimental
conﬁrmation of function that gives credibility to func-
tional annotation and therefore EMBL-Bank sees the
capture of experimentally derived annotation as a high
priority; the body of experimentally validated features in
EMBL-Bank provides a clean dataset for the development
of bioinformatic tools to establish function across
the large volumes of unannotated sequence, for which
the means are not available to run programmes of
experimental interpretation.
To reﬂect the above, the recording of the nature of
evidence for a particular annotated feature is considered to
be very important to EMBL-Bank and is under continual
review. The convention of annotation by inference, where
the /inference qualiﬁer is used to provide a controlled
hierarchical description of the inference (such as details of
an object in a remote database to which the sequence in
question is related or the ab initio tool which has been used
to interpret the sequence in question) has been further
developed in 2007 tobegin to restrict the secondterm of the
controlled vocabulary. The description of experimental
evidence for features, using the /experiment qualiﬁer, does
not as yet take advantage of a restricted vocabulary; while
this would be desirable, ENA was not able to ﬁnd a pre-
existing vocabulary with the breadth required. Work
continues within the submission environment development
Table 2. Points of entry to the European Nucleotide Archive—submissions, retrieval and support
Tool Point of entry
Submission Project registration http://www.ebi.ac.uk/embl/Submission/index.html
Trace submission
Sequence/annotation new data and updates
Retrieval SRS http://srs.ebi.ac.uk
Homology search—EMBL-Bank http://www.ebi.ac.uk/Tools/similarity.html
Homology search—ETA http://trace.ensembl.org/cgi-bin/tracesearch
Sequence Version Archive http://www.ebi.ac.uk/cgi-bin/sva/sva.pl
EMBL-Bank FTP http://www.ebi.ac.uk/embl/Access/index.html#ftp
ETA FTP ftp://ftp.ensembl.org/pub/traces/
Genomes http://www.ebi.ac.uk/genomes/
Dbfetch http://www.ebi.ac.uk/cgi-bin/emblfetch
Wsdbfetch http://www.ebi.ac.uk/Tools/webservices/WSDbfetch.html
Custom EMBL-Bank datasets datasubs@ebi.ac.uk
EMBL World http://www3.ebi.ac.uk/Services/EMBLWorld/EMBLWorld.pl
Custom ETA datasets trace-request@ensembl.org
Support Help datasubs@ebi.ac.uk
General Information http://www.ebi.ac.uk/embl/
News http://www.ebi.ac.uk/embl/News/news.html
Forthcoming Changes http://www.ebi.ac.uk/embl/Documentation/forthcomingchanges.html
XML Documentation http://www.ebi.ac.uk/embl/Documentation/xml/
EMBL-Bank User Manual http://www.ebi.ac.uk/embl/Documentation/User_manual/usrman.html
EMBL-Bank Feature Table Deﬁnition Document http://www.ebi.ac.uk/embl/Documentation/FT_deﬁnitions/feature_table.html
ETA Format Documentation http://trace.ensembl.org/
Table 1. Description of source metadata in EMBL-Bank
Qualiﬁer type Qualiﬁers
Molecule-related /mol_type
, /chromosome, /segment, /clone, /clone_lib, /map, /PCR_primers
, /sub_clone, /tissue_library
‘Parent’ setting /virion, /proviral, /germline, /rearranged, /focus, /macronuclear, /organelle
, /plasmid
‘Parent’ organism /organism
, /strain, /variety
, /cultivar, /sub_species
, /sub_strain, /transgenic, /ecotype, /identiﬁed_by, /pop_variant,
/serotype, /serovar, /sex, speciment_voucher
, /culture_collection
, /bio_material

‘Parent’ resolution /dev_stage, /tissue_type, /cell_line
Sampling /environmental_sample, /lat_lon
, /collected_by, /isolate, /collection_date, /country
, /isolation_source, /lab_host
Integrative /citation
, /db_xref, /label, /speciﬁc_host
Miscellaneous /note
The table shows a classiﬁcation of source qualiﬁers used in the description of source molecules in EMBL-Bank. Those marked with
 are mandatory,
those marked with
 take controlled vocabularies and those marked with
 take additional granular structure.
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contribute /inference and /experiment information across
their submissions.
Coding sequence annotation is among the most
important areas in which ENA can serve users; not only
for direct users of EMBL-Bank, but also for users of
UniProtKB, for which EMBL-Bank coding regions
are a primary source (10). Much is done to ensure that
representations of coding sequence are biologically
accurate. Coding sequence (CDS) features, for example,
have for many years been validated in all entries for
appropriate start and stop codons, taking into account
translation table choice, any known translation excep-
tions, ribosomal slippage and RNA editing. More
recently, technology has been implemented at EMBL-
EBI that ensures that annotated post-translational clea-
vage events are validated for out-of-frame cleavage events.
Where possible, gene symbols and product names
from established nomenclatures are captured, along with
systematic /locus_tag identiﬁers and EC numbers (see
‘Nomenclatures and Ontologies’, below).
In late 2007, EMBL-Bank introduced the new feature,
ncRNA, for non-protein-coding RNA genes. This new
feature consolidates a number of pre-existing non-coding
gene features, scRNA, snRNA and snoRNA, and draws
in gene types that previously did not have features, such as
microRNA. Given their extensive existing use, rRNA
and tRNA features will remain. While computational
tools exist to validate some families of non-coding genes,
their application in the validation of EMBL-Bank
annotation has generally not yet taken place since speciﬁc
technical implementation needs to be developed for
each tool. For ribosomal RNA annotation, though, all
curated 16S and 18S rRNA submissions are subject to
homology comparison validation (for feature length
and orientation) against reference sets of manually
selected genes. We expect to be able to extend the
reference set to cover additional rRNA genes and are
currently working with DDBJ and GenBank to establish a
minimal validation standard for all rRNA annotations.
Gene splicing patterns (shown as intron, exon and
mRNA features in EMBL ﬂatﬁle format) provide users
with important information. While consensus splice
sequences are known, the existence of consensus sites
where splicing is not seen and of large numbers of splice
sites that deviate signiﬁcantly from the consensus make
automated validation of annotated splice sites diﬃcult.
Clearly, for the coding regions of protein-coding genes,
translation constraints provide some validation of splice
patterns, but there is no systematic computational
validation available outside these regions. Investigations
into how evidence for splice sites can best be captured
reliably (using /inference and /experiment qualiﬁers) from
submitters will take place in the coming year, but it is
likely that responsibility for validation of reported splice
events will be delegated to such resources such as the
Alternative Splicing and Transcript Diversity database
(11) and Ensembl (12).
A number of structures exist for the representation of
repeated sequence in EMBL-Bank, covering satellites,
microsatellites, Alu repeats and so on. Work is currently
underway at the INSDC to improve the classiﬁcation of
repeats. Although we will strive to provide the appropriate
annotation structures for repeated sequences, because
repeats are commonly imperfect, it is not currently
considered practical to establish any further validation.
Signal and bind features, such as promoter,
CAAT_signal, GC_signal, RBS, polyA_signal, attentua-
tor, enhancer, primer_bind and protein_bind, have
established structures within EMBL-Bank. For some,
strong rules may be formulated for their prediction; these
rules may require knowledge of adjacent features.
For others, extensive experimental work along with the
study of homologues will be required. These features,
then, will be the focus of rationalization over the coming
years; for those signals that are seen to be entirely
predictable, we will either implement validation for
stored annotation or will not store them, but rather
generate them as part of data presentation; for those
signals that cannot be predicted, we will investigate ways
in which we can capture structured evidence for the
submitted annotation.
Integration data
ENA, particularly EMBL-Bank, oﬀers integration with
broader bioinformatic data through a number of struc-
tures that are brieﬂy reviewed in this section. The
importance of coverage and synchrony will continue to
guide the development of integration structures. EMBL-
Bank approaches integration in a very diﬀerent way from
its INSDC partners; systematic cross-references are
sought from external resources to which EMBL-Bank
will cross-refer and are not accepted from sequence data
submitters, internal cross-references to EMBL-Bank and
ETA records are oﬀered and integration with the suite of
EBI tools is central to the integration service. These
structures are presented in EMBL-Bank ﬂatﬁle and XML
formats and in SRS and DBfetch HTML views, are
marked up with hyperlinks to the appropriate services.
References to the literature have been explicit in EMBL-
Bank from the outset. With the increasing diversity of
publication media and availability of traditional literature
online, a number of developments at EMBL-Bank are
underway to maximize the utility of literature references.
Already in existence is technology that maps stored pub-
lications in EMBL-Bank to records from remote resources
via the PubMed identiﬁer system maintained by the US
National Library of Medicine. This yields cross-references,
seen as RX lines in EMBL ﬂatﬁle format, from each
publication cited in an EMBL-Bank sequence entry to
online literature services at the EBI, namely SRS (Table 2)
and CitExplore (http://www.ebi.ac.uk/citexplore/). These
two services provide similar reciprocal cross-references
from citations to EMBL-Bank entries. During 2007, work
was undertaken to extend this mapping technology to
capture links to publications indexed by resources other
than PubMed. The ﬁrst examples of such publications are
indexed by the Agricola service from the US National
Agriculture Library (NAL) of the US Department of
Agriculture (USDA) and not by PubMed; at the time of
going to press, there were 3769 literature items cited in
D10 Nucleic Acids Research, 2008, Vol. 36, DatabaseissueEMBL-Bank from Agricola alongside 193423 items from
PubMed.
Internal cross-references are provided in EMBL-Bank
sequence-annotation entries. These include links from
segment entries to CON and ANN records, links from
primary entries to TPA entries, links from TPA entries to
component ETA traces, links to stored alignment data in
EMBL Align and others.
External cross-references are under careful curation.
In2007,cross-referencestoanumberofnewresourceswere
added to EMBL-Bank sequence entries. These resources
are Genome Reviews, the IPD-Killer-cell Immunoglobu-
lin-like Receptor Database, RFAM—the RNA families’
database (13), the Culture Collection of Algae and
Protozoa (14) and the Alternative Splicing and Transcript
Diversity database (11). The cross-referencing system
allows entry-level and feature level cross-references, shown
as DR lines and /db_xref qualiﬁers respectively in EMBL
ﬂatﬁle format. Feature-level cross-references are currently
restricted to source and CDS features, although develop-
ments are underway to improve the technology to cover
additional features. While explicit cross-references to
speciﬁcfunctionalresources,suchasthewwPDBstructural
database, are attractive, links to these resources are largely
the domain of more specialist domain databases, such as
the UniProt Knowledgebase, and given an explicit link
to the speciﬁc resource from the domain database, a link
can be inferred from an EMBL-Bank entry that explicitly
cross-refers to the domain database. Priority for the
addition of new cross-references will be given to those
resources that oﬀer information on or physical links to
collections of biological materials that serve as source for
sequencing.
Whereas ETA records single unassembled reads,
EMBL-Bank sequences may be assembled to various
levels; anywhere from overlapping reads through scaﬀolds
with sequencing gaps to complete chromosomes, such that
contiguous sequence, regardless of length, can be repre-
sented in a single sequence-annotation entry. Explicit
links between ETA and EMBL-Bank are limited; traces
that have been assembled into reference sequence in
EMBL-Bank can be linked through the optional
Reference_Sequence ﬁeld in ETA and EMBL-Bank TPA
entries may refer to ETA traces that have been used in re-
assemblies (in AS lines in EMBL ﬂatﬁle format).
However, links to reference sequence in ETA records are
sparsely used and there are few EMBL-Bank TPA entries
that cite ETA records. Above the level of assembly of
ETA reads, EMBL-Bank oﬀers explicit links between
contigs and scaﬀold entries (CO lines in EMBL ﬂatﬁle
format) and between primary entries cited in TPA entries
(AS lines in EMBL ﬂatﬁle format). The value to users of
being able to map from trace reads through contigs and
upwards to annotated scaﬀolds is to be investigated across
EMBL-Bank and ETA, with a view to the development of
additional tools to extract and present this information.
Nomenclatures and ontologies
The adoption of appropriate community-accepted nomen-
clatures and ontologies is key to capturing useful source
metadata and biological annotation. Systematic nomen-
clatures, such as gene symbol conventions and strain
names, are crucial in the presentation of robust search
tools. However, the breadth of coverage (of, for example,
taxonomy, gene nomenclature and experimental techni-
ques) at ENA requires the use of multiple, often over-
lapping, nomenclatures. Many of the source metadata
structures in use have application across a broad
taxonomic range and across a variety of research
communities. In diﬀerent taxa, standard ways of referring
to concepts have developed, but they are typically not
consistent between taxa. Similarly, in diﬀerent commu-
nities of researchers, diverse systematic ways of referring
to concepts have evolved.
Once database staﬀ has established that there is an
existing vocabulary that has community acceptance,
we will aim to make mandatory the usage of the
vocabulary in appropriate ﬁelds in aﬀected records.
Nomenclatures that are promoted during EMBL-Bank
curated submissions processing are detailed at: http://
www.ebi.ac.uk/embl/Documentation/useful.html.
Projectmetadata
As increasing numbers of genomes and metagenomes are
sequenced, the presentation of metadata surrounding
sequencing activities will become increasingly useful in
searches and analyses. Improvement of the content of the
ENA Project Database is possible, since although many
metadata elements will be diﬃcult to validate automati-
cally, the database is currently comparatively small. ENA
therefore plans to improve existing records over the
coming years and follows keenly the standardization
work of the Genomic Standards Consortium (15).
SELECTED DATA CAPTURE PRIORITIES
(i) Sequence.
(ii) Sequencing-associated information (traces, quality
scores, base calls).
(iii) Coding sequence and related annotation.
(iv) Experimentally conﬁrmed annotation.
(v) The nature of evidence for annotation.
(vi) Source metadata nomenclatures and ontologies.
(vii) Cross-references to those resources that oﬀer infor-
mation on, or physical links to, collections of
biological materials.
(viii) Reference to the literature.
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